4.2 Article

Medical management of rhinitis in pregnancy

Journal

AURIS NASUS LARYNX
Volume 49, Issue 6, Pages 905-911

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.anl.2022.01.014

Keywords

Rhinitis; Allergy; Rhinology; Pregnancy; Management

Ask authors/readers for more resources

Medical treatment options for rhinitis during pregnancy should be carefully considered, taking into account the causes of rhinitis. Conservative treatment is important for pregnant women with pregnancy-induced rhinitis or pre-existing allergic or non-allergic rhinitis. Safe strategies such as exercise, positioning, saline nasal douching, and nasal valve dilators can provide relief for these patients. The use of common medical therapies for rhinitis may not be suitable for pregnant patients due to potential teratogenic effects, but topical corticosteroids such as budesonide are generally considered safe.
Medical treatment options for patients with rhinitis during pregnancy need careful considerations. It is important to distinguish between the causes of rhinitis, as this can influence treatment. Con-servative options are important for patients with pregnancy-induced rhinitis (PIR) and pre-existing allergic or non-allergic rhinitis. Education and knowledge that PIR symptoms will resolve af-ter pregnancy can offer some relief. Other strategies such as exercise, positioning, saline nasal douching/lavage, and nasal valve dilators are safe in pregnancy and can have a benefit in these patients with rhinitis of any aetiology. The main medical therapies usually used in rhinitis can-not always be directly translated to pregnant patients due to potential teratogenic effects. Topical corticosteroids have generally shown to be safe with budesonide having the strongest recommen-dations. Oral corticosteroids are mostly used in moderate-severe disease and should be avoided in the first trimester. Oral decongestants have associations with cardiac, ear, gut and limb ab-normalities and are not recommended in the first trimester. Loratadine and cetirizine have been the most well-studied second-generation antihistamines and are generally considered safe. There has been no reported increased risk of teratogenicity with anticholinergics or cromones, with the latter being one of the first line options in pregnant women with allergic rhinitis. The role of allergen immunotherapy needs further research, but current guidance states it can be continued if already initiated prior to pregnancy. The management of rhinitis in pregnancy can therefore be complex. This review aims to evaluate the current medical management options for rhinitis in pregnancy.(c) 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available